(Q56058409)

1

0 references

Ying Fu

2

0 references

Sabine H. van Rijt

4

0 references

Patricia A. Cooper

5

0 references

Paul M. Loadman

6

0 references

Peter J. Sadler

Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone

7

0 references

publication date

2011

0 references

published in

MedChemComm

0 references

volume

2

0 references

issue

7

0 references

page(s)

666

0 references

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Bioorganometallic fulvene-derived titanocene anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Titanium complexes in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Metal-based antitumour drugs in the post genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

DNA Interactions of Monofunctional Organometallic Ruthenium(II) Antitumor Complexes in Cell-free Media

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Catalytic organometallic anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Organometallic osmium arene complexes with potent cancer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Fluorescence probes used for detection of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1MD00075F